
Bioceres Crop Solutions Corp.
BIOXNASDAQBasic MaterialsAgricultural Inputs
常规交易时段
US$0.4279
−US$0.013 · -2.95%
BIOX公司概览
盘中时间采用ET。市场数据可能有所延迟。
GoAI 研究快照
简明呈现最新可用的模型信息。
GoAI评分
Sell
Trim exposure — unfavorable risk-reward
估值
47
Fair Value
动量
19
Strong Down
情绪
40
Bearish
风险韧性
34
High Risk
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
人工智能生成的上下文仅供参考,并非投资建议。
公司概况
公司网站Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
- 行业
- Agricultural Inputs
- 部门
- Basic Materials
- 总部
- AR
- 首席执行官
- Federico Trucco
- 上市以来
- 2018年3月22日
- 雇员
- 751
市场位置
日内区间
当前US$0.4279,
52周区间
当前US$0.4279,
- 开盘价
- US$0.44
- 前收盘价
- US$0.4409
- 成交量
- 2.3万
- 0.09× 平均值
- 平均成交量
- 24.74万
- 日均成交量
- 市值
- 2705.53万 USD
- 贝塔
- 0.4
- 市场参考 1
- 50天平均值
- US$0.3669
- 高于平均水平+16.63%
- 200天平均值
- US$0.7566
- 低于平均水平-43.45%
财务数据
财务快照
最近十二个月估值与收益率
- 企业价值
- 5.26亿 USD
- EV/EBITDA
- -53.94×
- 盈利收益率
- -19.62%
- 自由现金流收益率
- 12.49%
盈利能力和效率
- 净资产收益率
- -21.09%
- 资产收益率
- -7.26%
- 投入资本回报率
- -0.12%
财务健康
- 流动比率
- 0.91×
分析师评级
第三方分析师预期可能变化,并非 GoAI 建议。
评级分布
5项评级BIOX同业公司
持有BIOX的ETF
报告持有此股票敞口的交易所交易基金。
继续GoAI的研究
在 GoAI 中研究BIOXresearch.disclaimer






